Korean J Lab Med.  2009 Jun;29(3):199-203. 10.3343/kjlm.2009.29.3.199.

A Novel Translocation t(1;5)(p32;q31) that Was Not Associated with the TAL1 Rearrangement in a Case of T Lymphoblastic Leukemia/Lymphoma

Affiliations
  • 1Department of Laboratory Medicine, Yeungnam University College of Medicine, Daegu, Korea. chscp@med.yu.ac.kr
  • 2Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.
  • 3Department of Pathology, Yeungnam University College of Medicine, Daegu, Korea.

Abstract

Chromosome 1 band p32 (1p32) aberrations are common in T lymphoblastic leukemia/lymphoma (T-ALL/LBL). Two types of 1p32 aberrations include translocations with different partners and submicroscopic interstitial deletion. Both aberrations are known to result in TAL1 gene deregulation. The t(1;5)(p32;q31) is a rare translocation of 1p32 in T-ALL. We now present the second case of t(1;5)(p32;q31) in T-ALL, which was present as a primary cytogenetic abnormality, with a review of the relevant literature. Interestingly, neither the translocation of the TAL1 gene nor aberrant expression of TAL1 protein was detected by fluorescent in situ hybridization (FISH) and by immunohistochemical staining in this case.

Keyword

T-ALL; t(1;5)(p32;q31); TAL1 gene

MeSH Terms

Basic Helix-Loop-Helix Transcription Factors/*genetics/metabolism
Bone Marrow/pathology
Chromosomes, Human, Pair 1
Chromosomes, Human, Pair 5
Humans
Karyotyping
Male
Middle Aged
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/*diagnosis/genetics/pathology
Proto-Oncogene Proteins/*genetics/metabolism
Tomography, X-Ray Computed
*Translocation, Genetic

Figure

  • Fig. 1. (A) The bone marrow aspirates (Wright stain, ×1,000) and (B) biopsy (hematoxylin and eosin stain, ×200) showed an increase of small to medium sized blasts.

  • Fig. 2. The representative karyotype showed 46,XY,t(1;5) (p32;q31). Translocation chromosomes are indicated by arrows (GTG banding, ×1,000).

  • Fig. 3. The TAL1 gene translocation or submicroscopic deletion was not detected by FISH (×1,000).

  • Fig. 4. Immunohistochemical stainings for TAL1 were negative. (A) 2TL242 on bone marrow, (B) BTL73 on bone marrow, (C) 2TL242 on lymph node, (D) BTL73 on lymph node (×400).


Reference

1.Swerdlow SH, Campo E, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed.Lyon: IARC press;2008. p. 14–5.
2.Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman. (Updated on Nov. 2008.
3.Carroll AJ., Crist WM., Link MP., Amylon MD., Pullen DJ., Ragab AH, et al. The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1990. 76:1220–4.
Article
4.Fitzgerald TJ., Neale GA., Raimondi SC., Goorha RM. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor β chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35). Blood. 1991. 78:2686–95.
5.Aplan PD., Raimondi SC., Kirsch IR. Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukemia. J Exp Med. 1992. 176:1303–10.
Article
6.François S., Delabesse E., Baranger L., Dautel M., Foussard C., Boasson M, et al. Deregulated expression of the TAL1 gene by t(1;5)(p32;q31) in patient with T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer. 1998. 23:36–43.
7.Kaleem Z., Shuster JJ., Carroll AJ., Borowitz MJ., Pullen DJ., Camitta BM, et al. Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): a Pediatric Oncology Group study. Leukemia. 2000. 14:238–40.
Article
8.van der Burg M., Poulsen TS., Hunger SP., Beverloo HB., Smit EM., Vang-Nielsen K, et al. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia. 2004. 18:895–908.
Article
9.Pulford K., Lecointe N., Leroy-Viard K., Jones M., Mathieu-Mahul D., Mason DY. Expression of TAL-1 proteins in human tissues. Blood. 1995. 85:675–84.
Article
10.Finger LR., Kagan J., Christopher G., Kurtzberg J., Hershfield MS., Nowell PC, et al. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA. 1989. 86:5039–43.
Article
11.Brown L., Cheng JT., Chen Q., Siciliano MJ., Crist W., Buchanan G, et al. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J. 1990. 9:3343–51.
Article
12.Huret JL. Atlas of genetics and cytogenetics in oncology and haematology. http://atlasgeneticsoncology.org. (Updated on Oct. 2008.
13.Bash RO., Crist WM., Shuster JJ., Link MP., Amylon M., Pullen J, et al. Clinical features and outcome of T-cell acute lumphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Blood. 1993. 81:2110–7.
14.van Grotel M., Meijerink JP., van Wering ER., Langerak AW., Beverloo HB., Buijs-Gladdines JG, et al. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia. 2008. 22:124–31.
Article
15.Cotterill S. Cancer Genetics Web. http://www.cancer-genetics.org. (Updated on Apr. 2003.
Full Text Links
  • KJLM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr